Skip to main content
Fig. 2 | Biomaterials Research

Fig. 2

From: Reduced restenosis and enhanced re-endothelialization of functional biodegradable vascular scaffolds by everolimus and magnesium hydroxide

Fig. 2

Degradation behavior and drug release profile. The changes of (A) pH value, (B) residual weight, and (C) cumulative release of MH during degradation in PBS solution with 0.02 mg/mL proteinase K for 7 days at 37 °C. (D) Cumulative release of EVL from BVS/EVL and BVS/EVL/mMH in PBS solution for 28 days at 37 °C

Back to article page

Biomaterials Research

ISSN: 2055-7124

Contact us